TME PHARM.CONF.IPO EO 1- Net Asset Quality Index
TME PHARM.CONF.IPO EO 1- net asset quality index. TME PHARM.CONF.IPO EO 1- (0N6A) has a Net Asset Quality Index of -73.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.14 Million minus total liabilities of €3.72 Million yields net assets of €-1.58 Million. A higher index indicates a stronger, lower-leverage balance sheet. See TME PHARM.CONF.IPO EO 1- (0N6A) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of TME PHARM.CONF.IPO EO 1- (2021–2025)
Net asset quality index of TME PHARM.CONF.IPO EO 1- from 2021 to 2025. This chart shows how TME PHARM.CONF.IPO EO 1-'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at -73.8%, representing net assets of €-1.58 Million against total assets of €2.14 Million EUR. Check how tangible is TME PHARM.CONF.IPO EO 1-'s equity to evaluate the tangible quality of the company's equity base.
TME PHARM.CONF.IPO EO 1- Net Asset Quality Index by Year (2021–2025)
TME PHARM.CONF.IPO EO 1- net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for TME PHARM.CONF.IPO EO 1- from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 0N6A market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -73.8% | €-1.58 Million | €2.14 Million | €3.72 Million | ▼ -121.2 pp |
| 2024 | 47.4% | €1.61 Million | €3.41 Million | €1.79 Million | ▲ +59.2 pp |
| 2023 | -11.8% | €-294.00K | €2.49 Million | €2.79 Million | ▲ +12.5 pp |
| 2022 | -24.3% | €-1.27 Million | €5.24 Million | €6.51 Million | ▼ -70.4 pp |
| 2021 | 46.1% | €4.50 Million | €9.77 Million | €5.27 Million | — |